HTRN Htetf (MM)

HealthTronics, Inc. (NASDAQ:HTRN), today announced that it has opened its anatomical pathology laboratory whose primary focus is service to the urology community. The lab is located in a modern life sciences building on the campus of the Medical College of Georgia. John Q. Barnidge, Interim President & CEO, said, "We are very proud of this new facility which offers state of the art technology and equipment. Our customers and physician partners will benefit from technological innovations, including web-based reporting capabilities and bar code assisted workflow. With input from our physician partners, we have also developed a unique, patent-pending biopsy kit to maximize efficiencies and quality assurance for both the physician and lab personnel. We are fortunate to have a talented and experienced clinical staff and pathologist working with us. Mr. Barnidge concluded, "I am looking forward to discussing more aspects about this new business, including a recent long-term contract that we entered into with a local Georgia hospital to outsource its lab services, during our March 9, 2006 conference call." About HealthTronics, Inc. HealthTronics provides healthcare services primarily to the Urology community and manufactures and distributes medical devices. The Company also manufactures specialty vehicles used for the transport of high-technology medical devices and broadcast & communications equipment. For more information, visit www.healthtronics.com. Statements by the Company's management during the conference call announced in this press release that are not strictly historical, including statements regarding plans, objective and future financial performance, are "forward-looking" statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although HealthTronics believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that the expectations will prove to be correct. Factors that could cause actual results to differ materially from HealthTronics' expectations include, among others, the existence of demand for and acceptance of HealthTronics' services, regulatory approvals, economic conditions, the impact of competition and pricing, financing efforts and other factors described from time to time in HealthTronics' periodic filings with the Securities and Exchange Commission.